deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02185339

Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics

Effects of Deep Versus Moderate Neuromuscular Blockade on Intraoperative Respiratory Mechanics in Patients Undergoing Laparoscopic Renal Surgery: a Prospective, Randomized, Parallel Design Study

Sponsor: Merck Sharp & Dohme LLC

Interventions Rocuronium
Updated 9 times since 2017 Last updated: Jun 23, 2016 Started: Jul 31, 2014 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Laparoscopic Renal Surgery and Laparoscopy, this trial is completed. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jun 2022 · 17 months · monthly snapshotCompleted~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

Show 4 earlier versions
  1. Jun 2022 — Dec 2022 [monthly]

    Completed PHASE4

  2. Jan 2021 — Jun 2022 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck Sharp & Dohme LLC
  • Seoul St. Mary's Hospital
Data source: Seoul St. Mary's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations